Literature DB >> 18478666

Mental health and substance abuse insurance parity for federal employees: how did health plans respond?

Colleen L Barry1, M Susan Ridgely.   

Abstract

A fundamental concern with competitive health insurance markets is that they will not supply efficient levels of coverage for treatment of costly, chronic, and predictable illnesses, such as mental illness. Since the inception of employer-based health insurance, coverage for mental health services has been offered on a more limited basis than coverage for general medical services. While mental health advocates view insurance limits as evidence of discrimination, adverse selection and moral hazard can also explain these differences in coverage. The intent of parity regulation is to equalize private insurance coverage for mental and physical illness (an equity concern) and to eliminate wasteful forms of competition due to adverse selection (an efficiency concern). In 2001, a presidential directive requiring comprehensive parity was implemented in the Federal Employees Health Benefits (FEHB) Program. In this study, we examine how health plans responded to the parity directive. Results show that in comparison with a set of unaffected health plans, federal employee plans were significantly more likely to augment managed care through contracts with managed behavioral health "carve-out" firms after parity. This finding helps to explain the absence of an effect of the FEHB Program directive on total spending, and is relevant to the policy debate in Congress over federal parity.

Entities:  

Mesh:

Year:  2008        PMID: 18478666     DOI: 10.1002/pam.20311

Source DB:  PubMed          Journal:  J Policy Anal Manage        ISSN: 0276-8739


  9 in total

1.  Economic grand rounds: the price is right? Changes in the quantity of services used and prices paid in response to parity.

Authors:  Howard H Goldman; Colleen L Barry; Sharon-Lise T Normand; Vanessa Azzone; Alisa B Busch; Haiden A Huskamp
Journal:  Psychiatr Serv       Date:  2012-02-01       Impact factor: 3.084

2.  The Mental Health Parity and Addiction Equity Act evaluation study: Impact on specialty behavioral health utilization and expenditures among "carve-out" enrollees.

Authors:  Susan L Ettner; Jessica M Harwood; Amber Thalmayer; Michael K Ong; Haiyong Xu; Michael J Bresolin; Kenneth B Wells; Chi-Hong Tseng; Francisca Azocar
Journal:  J Health Econ       Date:  2016-09-30       Impact factor: 3.883

3.  Assessing incentives for service-level selection in private health insurance exchanges.

Authors:  Thomas G McGuire; Joseph P Newhouse; Sharon-Lise Normand; Julie Shi; Samuel Zuvekas
Journal:  J Health Econ       Date:  2014-02-17       Impact factor: 3.883

4.  Do coverage mandates affect direct-to-consumer advertising for pharmaceuticals? Evidence from parity laws.

Authors:  Robert Nathenson; Michael R Richards
Journal:  Int J Health Econ Manag       Date:  2018-01-29

5.  The Role of Behavioral Health Diagnoses in Adverse Selection.

Authors:  Michelle S Keller; Haiyong Xu; Francisca Azocar; Susan L Ettner
Journal:  Psychiatr Serv       Date:  2020-05-22       Impact factor: 3.084

6.  Behavioral health services in separate CHIP programs on the eve of parity.

Authors:  Rachel L Garfield; William R Beardslee; Shelly F Greenfield; Ellen Meara
Journal:  Adm Policy Ment Health       Date:  2012-05

7.  Implications of the Mental Health Parity and Addiction Equity Act.

Authors:  Susan H Busch
Journal:  Am J Psychiatry       Date:  2012-01       Impact factor: 18.112

8.  The effects of mental health parity on spending and utilization for bipolar, major depression, and adjustment disorders.

Authors:  Alisa B Busch; Frank Yoon; Colleen L Barry; Vanessa Azzone; Sharon-Lise T Normand; Howard H Goldman; Haiden A Huskamp
Journal:  Am J Psychiatry       Date:  2013-02       Impact factor: 18.112

9.  Federal parity law associated with increased probability of using out-of-network substance use disorder treatment services.

Authors:  Emma E McGinty; Susan H Busch; Elizabeth A Stuart; Haiden A Huskamp; Teresa B Gibson; Howard H Goldman; Colleen L Barry
Journal:  Health Aff (Millwood)       Date:  2015-08       Impact factor: 6.301

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.